These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2656396)

  • 21. Molecular structure and function of the bacteriocin gene and bacteriocin protein of plasmid Clo DF13.
    van den Elzen PJ; Walters HH; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1983 Apr; 11(8):2465-77. PubMed ID: 6344017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient production of extracellular proteins with Escherichia coli by means of optimized coexpression of bacteriocin release proteins.
    Sommer B; Friehs K; Flaschel E
    J Biotechnol; 2010 Feb; 145(4):350-8. PubMed ID: 19958803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular structure of the immunity gene and immunity protein of the bacteriocinogenic plasmid Clo DF13.
    van den Elzen PJ; Gaastra W; Spelt CE; de Graaf FK; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1980 Oct; 8(19):4349-63. PubMed ID: 6253914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and excretion of cloacin DF13 by Escherichia coli harboring plasmid CloDF13.
    Van Tiel-Menkvled GJ; Rezee A; De Graaf FK
    J Bacteriol; 1979 Nov; 140(2):415-23. PubMed ID: 227839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcloning of the cloacin DF13/aerobactin receptor protein and identification of a pColV-K30-determined polypeptide involved in ferric-aerobactin uptake.
    Krone WJ; Luirink J; Koningstein G; Oudega B; de Graaf FK
    J Bacteriol; 1983 Nov; 156(2):945-8. PubMed ID: 6313629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression in Escherichia coli K-12 of the 76,000-dalton iron-regulated outer membrane protein of Shigella flexneri confers sensitivity to cloacin DF13 in the absence of Shigella O antigen.
    Derbyshire P; Baldwin T; Stevenson P; Griffiths E; Roberts M; Williams P; Hale TL; Formal SB
    Infect Immun; 1989 Sep; 57(9):2794-8. PubMed ID: 2474501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF13: purification and characterization of the immunity protein.
    Kool AJ; Pols C; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):67-75. PubMed ID: 1099983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13.
    Akutsu A; Masaki H; Ohta T
    J Bacteriol; 1989 Dec; 171(12):6430-6. PubMed ID: 2687234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of the cloacin DF13-immunity protein.
    Oudega B; Klaasen-Boor P; De Graaf FK
    Biochim Biophys Acta; 1975 May; 392(1):184-95. PubMed ID: 1092372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein release in recombinant Escherichia coli using bacteriocin release protein.
    Yu P; San KY
    Biotechnol Prog; 1992; 8(1):25-9. PubMed ID: 1367893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutants of the Clo DF13 plasmid in Escherichia coli with a decreased bacteriocinogenic activity.
    Andreoli PM; Nijkamp HJ
    Mol Gen Genet; 1976 Mar; 144(2):159-70. PubMed ID: 775289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. tolQ is required for cloacin DF13 susceptibility in Escherichia coli expressing the aerobactin/cloacin DF13 receptor IutA.
    Thomas JA; Valvano MA
    FEMS Microbiol Lett; 1992 Mar; 70(2):107-11. PubMed ID: 1587457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and expression of the cloacin DF13/aerobactin receptor of Escherichia coli (ColV-K30).
    Krone WJ; Oudega B; Stegehuis F; de Graaf FK
    J Bacteriol; 1983 Feb; 153(2):716-21. PubMed ID: 6218156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino terminus of outer membrane PhoE protein: localization by use of a bla-phoE hybrid gene.
    Tommassen J; Lugtenberg B
    J Bacteriol; 1984 Jan; 157(1):327-9. PubMed ID: 6361002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of mutants in the study of structure-function relationships in cloacin DF13.
    Gaastra W; Oudega B; de Graaf FK
    Biochim Biophys Acta; 1978 May; 540(2):301-12. PubMed ID: 418820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro binding of cloacin DF13 to its purified outer membrane receptor protein and effect of peptidoglycan on bacteriocin-receptor interaction.
    Oudega B; van der Molen J; de Graaf FK
    J Bacteriol; 1979 Dec; 140(3):964-70. PubMed ID: 533771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of bacteriocin-release-protein-induced protein release by Escherichia coli: extracellular production of the periplasmic molecular chaperone FaeE.
    van der Wal FJ; ten Hagen-Jongman CM; Oudega B; Luirink J
    Appl Microbiol Biotechnol; 1995 Dec; 44(3-4):459-65. PubMed ID: 8597549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prolipoprotein signal peptide mutations on secretion of hybrid prolipo-beta-lactamase in Escherichia coli.
    Lunn CA; Inouye M
    J Biol Chem; 1987 Jun; 262(17):8318-24. PubMed ID: 3036809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF16: action of the immunity protein in vivo and in vitro.
    Kool AJ; Borstlap AJ; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):76-85. PubMed ID: 1099984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural determinants in addition to the amino-terminal sorting sequence influence membrane localization of Escherichia coli lipoproteins.
    Gennity JM; Kim H; Inouye M
    J Bacteriol; 1992 Apr; 174(7):2095-101. PubMed ID: 1551832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.